[1]. 【脱毛症治療】(治療2)病態を踏まえた円形脱毛症の治療アップデート
皮膚病診療 (株)協和企画 [巻]48 [号]2 [頁]116 -116-120 (2026年) [査読] 無
[DOI] [2]. Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey
[巻]76 [号]6 [頁]949 -962 (2024年) [査読] 有
[3]. Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Arthritis & rheumatology (Hoboken, N.J.) (2024年) [査読] 有
[DOI] [4]. 外的要因と抜け毛 新型コロナウイルス感染症も含めて
皮膚と美容 (公社)日本毛髪科学協会 [巻]55 [号]4 [頁]132 -132-138 (2023年) [査読] 有
[5]. Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
[巻]13 [号]11 [頁]2621 -2634 (2023年) [査読] 有